(18)F-labeled magnetic nanoparticles for monitoring anti-angiogenic therapeutic effects in breast cancer xenografts

PURPOSE: To develop a novel fluorine-18 ((18)F)-labeled arginine–glycine–aspartic acid (RGD)-coupled ultra-small iron oxide nanoparticle (USPIO) (hereafter, referred to as (18)F-RGD@USPIO) and conduct an in-depth investigation to monitor the anti-angiogenic therapeutic effects by using a novel dual-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanshu, Liu, Huanhuan, Yao, Defan, Li, Jinning, Yang, Shuyan, Zhang, Caiyuan, Chen, Weibo, Wang, Dengbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788012/
https://www.ncbi.nlm.nih.gov/pubmed/31604441
http://dx.doi.org/10.1186/s12951-019-0534-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788012/
https://www.ncbi.nlm.nih.gov/pubmed/31604441
http://dx.doi.org/10.1186/s12951-019-0534-7

Ejemplares similares